Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
The United States, whose deep cuts to foreign aid this year under President Trump have severely impacted Africa’s health ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
The United States has begun distributing a groundbreaking HIV-prevention treatment to two African nations, marking a ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today ...
The United States said Tuesday it has delivered a new treatment to prevent HIV in two African countries, months after ...
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
Administration officials say South Africa has “significant means” to fund a promising new drug, lenacapavir, on its own.
Last year, 444 people in the Netherlands were diagnosed with HIV, the virus that can cause AIDS. Almost 20 years ago, there ...
The United States said Tuesday it has delivered a new treatment to prevent HIV in two African countries, months after ...
The ECDC says the region could still meet its testing targets for HIV, but that it will be harder to improve detection for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback